Detalhe da pesquisa
1.
Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis.
Allergy
; 79(5): 1258-1270, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38108208
2.
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial.
Lancet
; 400(10348): 273-282, 2022 07 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35871814
3.
A detailed look at the European Medicines Agency's recommendations for use of Janus kinase inhibitors in patients with atopic dermatitis.
J Eur Acad Dermatol Venereol
; 37(10): 2041-2046, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37319107
4.
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.
J Eur Acad Dermatol Venereol
; 37(10): 2056-2066, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37335885
5.
Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension.
Dermatol Ther (Heidelb)
; 13(4): 935-950, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36949275
6.
Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary.
Immunotherapy
; 15(13): 975-980, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37254941
7.
The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: results of a prospective, multicenter, open-label study.
J Am Acad Dermatol
; 67(4): 642-50, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22153792
8.
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies.
Dermatitis
; 32(1S): S39-S44, 2021 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34175862
9.
Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial.
Dermatology
; 221(2): 172-8, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20628238
10.
Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical Trials.
J Rheumatol
; 43(6): 1063-7, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27134249
11.
Ultraviolet B-induced DNA damage in human epidermis is modified by the antioxidants ascorbic acid and D-alpha-tocopherol.
J Invest Dermatol
; 124(2): 304-7, 2005 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-15675947